ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Kane Biotech Inc

Kane Biotech Inc (KNE)

0.15
0.00
(0.00%)
Closed June 29 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.15
Bid
0.145
Ask
0.15
Volume
5,000
0.15 Day's Range 0.15
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.15
Open
0.15
Last Trade
5000
@
0.15
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
131,844,000
Dividend Yield
-
PE Ratio
-3.75
Earnings Per Share (EPS)
-0.04
Revenue
2.82M
Net Profit
-5.27M

About Kane Biotech Inc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Headquarters
Winnipeg, Manitoba, Can
Founded
1970
Kane Biotech Inc is listed in the Coml Physical, Biologcl Resh sector of the TSX Venture Exchange with ticker KNE. The last closing price for Kane Biotech was $0.15. Over the last year, Kane Biotech shares have traded in a share price range of $ 0.00 to $ 0.00.

Kane Biotech currently has 131,844,000 shares outstanding. The market capitalization of Kane Biotech is $19.78 million. Kane Biotech has a price to earnings ratio (PE ratio) of -3.75.

KNE Latest News

Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to ProgenaCare Global

WINNIPEG, Manitoba, June 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made its first commercial-scale sale of...

Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.

WINNIPEG, Manitoba, June 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has entered into a worldwide license agreement with...

Kane Biotech Announces First Quarter 2024 Financial Results

WINNIPEG, Manitoba, May 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its first quarter 2024 financial results. The...

Kane Biotech to Release First Quarter 2024 Financial Results on May 23, 2024

WINNIPEG, Manitoba, May 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development...

Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map

WINNIPEG, Manitoba, May 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces its intent to commercialize the patented...

Kane Biotech to Host Investor Webinar

WINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday April 18th, 2024 at 4:15pm...

Dual Listed Biotech Firm Achieves Sale of Animal Health Interest, Sending Shares Higher

Shares of this firm hit a 12-month high last week and are seeing action this morning after they announced the completion of the sale of its interest in an animal health unit for USD$8,000,000...

Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products

WINNIPEG, Manitoba, April 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that, it has completed the sale of its interest in STEM Animal Health Inc...

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - KNE

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - KNE Canada NewsWire VANCOUVER, BC, le 11 avril 2024 VANCOUVER, BC, le 11 avril 2024...

Canadian Investment Regulatory Organization Trade Resumption - KNE

Canadian Investment Regulatory Organization Trade Resumption - KNE Canada NewsWire VANCOUVER, BC, April 11, 2024 VANCOUVER, BC, April 11, 2024 /CNW/ - Trading resumes in: Company: Kane Biotech...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ASNSActelis Networks Inc
$ 2.3599
(59.45%)
71.61M
COSMCosmos Health Inc
$ 1.05
(54.64%)
81.3M
LUCYInnovative Eyewear Inc
$ 0.5036
(52.61%)
364.85M
NNENano Nuclear Energy Inc
$ 23.43
(44.45%)
9.41M
NBSTWNewbury Street Acquisition Corporation
$ 0.0613
(39.32%)
19.62k
CINGCingulate Inc
$ 0.315
(-46.06%)
2.36M
ACCDAccolade Inc
$ 3.53
(-44.76%)
14.63M
BTOGBit Origin Ltd
$ 2.95
(-44.55%)
3.3M
NXLNexalin Technologies Inc
$ 1.695
(-42.74%)
4.31M
APVOAptevo Therapeutics Inc
$ 0.309899
(-39.81%)
2.37M
LUCYInnovative Eyewear Inc
$ 0.507001
(53.64%)
356.92M
NVDANVIDIA Corporation
$ 124.3812
(0.32%)
248.1M
FFIEFaraday Future Intelligent Electric Inc
$ 0.513
(-14.50%)
189.18M
SQQQProShares UltraPro Short QQQ
$ 8.20
(0.86%)
142.65M
TSLATesla Inc
$ 196.72
(-0.35%)
82.53M

KNE Discussion

View Posts
teq0904 teq0904 6 months ago
They have been making about 2,500 samples per month in their lab for distribution to doctors for more than a month. By the time the contract plant starts up at the end of March there will be over 10k samples out so lots of doctors will be familiar with the product. You can bet they went to the burn centers and other of their top identified markets first.
👍️0
teq0904 teq0904 8 months ago
Latest video on kne
https://www.facebook.com/KaneBiotechInc/videos/292568703569665
👍️0
teq0904 teq0904 10 months ago
cc on Tuesday
👍️0
teq0904 teq0904 10 months ago
Doesn't matter what you think the dog market is, because it will be sold. Strategic review nr.
👍️0
teq0904 teq0904 10 months ago
First closing of the financing is probably next week. Officers and directors are in on it.
👍️0
teq0904 teq0904 11 months ago
On the previous cc, Edwards said it is possible that the FDA will approve the manufacturing plant in time for the sales to start in Q4.
👍️0
teq0904 teq0904 11 months ago
The next quarterly cc will be late in August.
👍️0
teq0904 teq0904 11 months ago
The next step is for the outsourced manufacturing of coactiv+ to be completed. It may already be done, but it was supposed to take 3 months after receiving FDA approval.
👍️0
teq0904 teq0904 11 months ago
They have FDA approval for coactiv+.
👍️0
J_Dean J_Dean 3 years ago
This is the year. Let’s go! :)
👍️0
Golden Cross Golden Cross 4 years ago
Kane Biotech Announces Third Quarter 2019
Financial Results

https://backend.otcmarkets.com/otcapi/company/dns/news/document/40388/content
👍️0
Golden Cross Golden Cross 4 years ago
KNBIF Website:

https://www.kanebiotech.com/
👍️0
Golden Cross Golden Cross 4 years ago
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (56 patents and patents pending, trade secrets and trademarks) and products developed by the Company’s own biofilm research expertise and acquired from leading research institutions. StrixNBTM, DispersinB®, Aledex®, bluestemTM, AloSeraTM, coactiv+TM and Kane® are trademarks of Kane Biotech Inc. The Company is listed on the TSX Venture Exchange under the symbol "KNE".
👍️0
Golden Cross Golden Cross 4 years ago
Monster # of filings today $KNBIF

https://www.otcmarkets.com/stock/KNBIF/disclosure
👍️0
sfld sfld 4 years ago
This might pump this week. Mentioned in a National Inflation Association newsletter today. GLTA
👍️0
pegcitygreen pegcitygreen 5 years ago
I live in Winnipeg and have personally worked with this company. Great people, great products, but the company itself always seems to struggle. Kane products are for wealthy/well off people who love their pets and more than likely do not have any kids. A very, very niche market. Their tradeshows booth is quite impressive...but that doesn't mean impressive sales.
👍️0
teq0904 teq0904 5 years ago
CEO got 2M shares in the market now.
👍️0
teq0904 teq0904 5 years ago
Jan 30 cc and presentation shows the potential markets. Just sign into it and you end up with the archive. https://edge.media-server.com/m6/p/rzpqebyy
👍️0
Macaveli Macaveli 6 years ago
Decent news released today. Plus insiders are buying. This is a hidden gem.
👍️0
teq0904 teq0904 6 years ago
Sales are slow for this startup, however the products are superb so I imagine it will be a good company in the long run. I used the oral rinse and shampoo for my dog. I don't know if the rinse is the reason, but the vet told me this month that her teeth are in excellent shape for her age.
She also had a bad itch last winter and scratched day and night. It didn't stop with the use of a vet's prescription shampoo, so I tried the Kane product with excellent results. As soon as I put it on her she stops scratching for about 1 day, so I just apply it once daily wherever I see her scratching.

I know a guy who had terrible psoriasis itching on the scalp all day and night long but it all stopped when he used the human shampoo.
👍️0

Your Recent History

Delayed Upgrade Clock